2020
DOI: 10.1016/j.molstruc.2020.127897
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, characterization, crystal structure and evaluation of four carbazole-coumarin hybrids as multifunctional agents for the treatment of Alzheimer’s disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
11
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(12 citation statements)
references
References 34 publications
1
11
0
Order By: Relevance
“…All the compounds showed greater inhibition of AChE than BuChE. In the designed compounds, the following structure-activity relationship were obtained: (i) compounds with a methyl group (3 b-f) on the coumarin scaffold (R 1 = CH 3 ) decreased the inhibitory activities of AChE more than the series of the compounds without the methyl group (3 h-l) except for 3 c, 3 i (n = 4), and 7 a and 7 g (linker as piperazine group), which was similar to other series of coumarin derivatives; [39,42] (ii) it was observed that the inhibitory activity toward AChE exhibited a notable rise in the compounds possessing longer hydrocarbon linkers, specifically in the cases of n = 4 to n = 12 for both series of IC 50 = 12.20 μM). It was possible that the active site of AChE consisted of many hydrophobic amino acids, such as phenylalanine and tryptophan, affecting the results for the of compounds 7 a, and 7 g, for which the linker piperazine displayed poor AChE inhibition.…”
Section: Cholinesterase Inhibitory Assay In 96-microtiter Well Platessupporting
confidence: 61%
“…All the compounds showed greater inhibition of AChE than BuChE. In the designed compounds, the following structure-activity relationship were obtained: (i) compounds with a methyl group (3 b-f) on the coumarin scaffold (R 1 = CH 3 ) decreased the inhibitory activities of AChE more than the series of the compounds without the methyl group (3 h-l) except for 3 c, 3 i (n = 4), and 7 a and 7 g (linker as piperazine group), which was similar to other series of coumarin derivatives; [39,42] (ii) it was observed that the inhibitory activity toward AChE exhibited a notable rise in the compounds possessing longer hydrocarbon linkers, specifically in the cases of n = 4 to n = 12 for both series of IC 50 = 12.20 μM). It was possible that the active site of AChE consisted of many hydrophobic amino acids, such as phenylalanine and tryptophan, affecting the results for the of compounds 7 a, and 7 g, for which the linker piperazine displayed poor AChE inhibition.…”
Section: Cholinesterase Inhibitory Assay In 96-microtiter Well Platessupporting
confidence: 61%
“…There are numerous accounts of the multifunctional carbazole moiety being utilized to treat AD. For instance, Choubdar, N. et al, developed new classes of carbazoles [ 88 ], Shi, D.H. et al, synthesized carbazole-coumarin hybrids [ 89 ], Bachurin, S.O. et al, synthesized novel conjugates of aminoadamantanes with carbazole derivatives [ 90 ], and Zhang, X. et al, developed novel multifunctional carbazole-amines [ 91 ].…”
Section: Inhibitionmentioning
confidence: 99%
“…In addition, 136 was able to bind both the CAS and PAS of cholinesterase, which suggested that it could interfere with PAS-induced β-amyloid aggregation. A different approach was followed by Shi and collaborators, who designed four derivatives obtained by coupling two pharmacophores (carbazole and coumarin) to obtain potential multitarget agents for the treatment of AD [170]. The aim was to exploit the biological activities of both the mentioned moieties: on one hand coumarins are known to have inhibitory activity on AChE, BuChE and MAO, besides antioxidant properties; on the other hand, carbazole exhibits antioxidant activity [171] and the ability to inhibit Aβ aggregation [172].…”
Section: Neuroprotection: Effect On Alzheimer's Diseasementioning
confidence: 99%